Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

Amgen’s Biosimilar Trends Report shows benefit of competition from biosimilars

Competition created by biosimilars has delivered $9.8bn in savings over five years and could reduce patients’ out-of-pocket costs by $238m

We Invest in People Gold logo

Cuttsy+Cuttsy awarded Gold accreditation by Investors in People

Healthcare communications agency, Cuttsy+Cuttsy, has been awarded ‘We invest in People, Gold’ from Investors in People.

Cuttsy + Cuttsy

- PMLiVE

Nudging someone in the right direction isn’t always easy – that’s where behavioural science comes in

By Dan Coffin

OPEN Health acquires ARK

OPEN Health Acquires ARK

OPEN Health has today announced the acquisition of London-based agency ARK to further strengthen omnichannel capabilities

OPEN Health

CHANGING FACES: UNDERSTANDING THE KEY CUSTOMER CONTACT POINTS WITHIN THE ICS LANDSCAPE

As well as creating new structures, the reforms underway within the NHS will see a considerable movement of people and power across the new Integrated Care Systems. Wilmington Healthcare’s Victoria...

Wilmington Healthcare

- PMLiVE

FDA approves Seagen/Genmab’s antibody-drug conjugate Tivdak for women with advanced cervical cancer

The drug has been granted accelerated approval, and the companies have also released positive data on first-line treatment

- PMLiVE

AstraZeneca chooses Ireland for $360m manufacturing site

The next-generation facility will make small molecule active ingredients, future-proofing the company’s supply chain and boosting the Irish life sciences sector

- PMLiVE

Building the perfect behaviour-change buffet

By Kirsty Mead

IBD Registry wins Communiqué award for COVID-19 tool

The IBD Registry has won a coveted Communiqué award in recognition of its collaborative efforts in creating the COVID-19 IBD Risk Tool for people with inflammatory bowel disease (IBD).

Dovetail

Havas Life Medicom named Agency Digital Team and leads agency wins at PM Digital Awards

Wins included three gold, three silver and two bronze across multiple categories

Havas Life London

Roche Basel Switzerland

New data for Tecentriq in early-stage lung cancer

Roche’s PD-L1 blocker reduced the risk of disease recurrence and death for patients with stage 2-3a non-small cell lung cancer following surgery

- PMLiVE

Strong five-year survival data for Kisqali in breast cancer

Novartis’ Kisqali plus letrozole offers more than a year survival benefit for postmenopausal women with HR+/HER2 advanced breast cancer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links